The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
SABRE: Assessment of safety and efficacy of 64Cu-SAR-BBN in patients with PSMA-negative biochemical recurrent prostate cancer.
 
Luke T. Nordquist
No Relationships to Disclose
 
Eva Lengyelova
Employment - Clarity Pharmaceuticals
Leadership - Clarity Pharmaceuticals
Stock and Other Ownership Interests - Clarity Pharmaceuticals
Travel, Accommodations, Expenses - Clarity Pharmaceuticals
 
Andrei Iagaru
Consulting or Advisory Role - Clarity Pharmaceuticals; Isotopen Technologien; Novartis; Telix Pharmaceuticals
Research Funding - Advanced Accelerator Applications (Inst); GE Healthcare (Inst); Progenics (Inst)
Travel, Accommodations, Expenses - GE Healthcare
 
Brandon Robert Mancini
Employment - BAMF Health
Stock and Other Ownership Interests - BAMF Health
Consulting or Advisory Role - GoodRx; MCG Health; RubiconMD
Speakers' Bureau - GE Healthcare
Travel, Accommodations, Expenses - BAMF Health; West Michigan Cancer Center
 
Hong Song
Consulting or Advisory Role - Lanth; Lanth
Research Funding - Clarity Pharmaceuticals (Inst)
 
Medhat Osman
Honoraria - Lantheus Medical Imaging
Speakers' Bureau - Lantheus Medical Imaging
 
David Josephson
No Relationships to Disclose
 
Frankis Almaguel
No Relationships to Disclose
 
Daniel Saltzstein
No Relationships to Disclose
 
Michelle Parker
Employment - Clarity Pharmaceuticals
Leadership - Clarity Pharmaceuticals
Stock and Other Ownership Interests - Clarity Pharmaceuticals
 
Robert M. Miller
Employment - Clarity Pharmaceuticals; Hubro Therapeutics; Scancell Ltd.
Stock and Other Ownership Interests - Hubro Therapeutics (Inst)
Consulting or Advisory Role - Clarity Pharmaceuticals; Scancell Ltd.
Travel, Accommodations, Expenses - Hubro Therapeutics; Scancell Ltd.
 
Neal D. Shore
Employment - GenesisCare
Leadership - Alessa Therapeutics; Photocure
Consulting or Advisory Role - Abbvie; AIkido Pharma; Amgen; Arquer Diagnostics; Asieris Pharmaceuticals; Astellas Pharma; AstraZeneca; Bayer; Boston Scientific; Bristol-Myers Squibb/Sanofi; CG Oncology; CG Oncology; Clarity Pharmaceuticals; Clovis Oncology; Dendreon; Exact Imaging; Exact Sciences; FerGene; Ferring; Fize Medical; Foundation Medicine; Genesis Cancer Care; Genzyme; Guardant Health; ImmunityBio; Incyte; InVitae; Janssen Scientific Affairs; Lantheus Medical Imaging; Lilly; MDxHealth; Medivation/Astellas; Merck; Minomic; Myovant Sciences; Myriad Genetics; NGM Biopharmaceuticals; Nonagen Bioscience; Novartis; Nymox; Pacific Edge Biotechnology; Peerview; Pfizer; Phosphorus; Photocure; PlatformQ Health; Profound Medical; Promaxo; Propella Therapeutics; Protara Therapeutics; Sanofi; Sesen Bio; Speciality Networks; Telix Pharmaceuticals; Tempus; Tolmar; Urogen pharma; Vaxiion; Vessi Medical
Speakers' Bureau - Astellas Pharma; AstraZeneca; Bayer; Clovis Oncology; Dendreon; Foundation Medicine; Guardant Health; Janssen; Merck; Pfizer
Research Funding - Abbvie; Advantagene; Amgen; Aragon Pharmaceuticals; Astellas Pharma; AstraZeneca; Bayer; Boston Scientific; Bristol-Myers Squibb/Pfizer; CG Oncology; Clovis Oncology; Dendreon; DisperSol; Endocyte; Exact Imaging; Exelixis; Ferring; FKD Therapies; FORMA Therapeutics; Foundation Medicine; Genentech; Guardant Health; InVitae; Istari Oncology; Janssen; Jiangsu Yahong Meditech; MDxHealth; Medivation; Merck; MT Group; Myovant Sciences; Myriad Genetics; Novartis; Nymox; OncoCellMDx; ORIC Pharmaceuticals; pacific edge; Palette Life Sciences; Pfizer; Plexxikon; POINT Biopharma; Propella Therapeutics; Propella Therapeutics; RhoVac; Sanofi; SeaGen; Sesen Bio; Steba Biotech; Theralase; Tolmar; Urogen pharma; Urotronic; US Biotest; Vaxiion; Veru; Zenflow
Expert Testimony - Ferring
Other Relationship - Alessa Therapeutics; Photocure